Göran Rådegran

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Polycyclic Aromatic Hydrocarbons

Epidermal Growth Factor Receptor

Pulmonary Arterial Hypertension

Top Venues

ESC heart failure

Pulmonary circulation

ERJ open research

European heart journal open

This page only lists publications with an associated author ORCID identifier.

Publications

Fabio Dardi, Athénaïs Boucly, Raymond L Benza, Robert P Frantz, Valentina Mercurio, Horst Olschewski, Göran Rådegran, Lewis J Rubin, Marius M Hoeper
Risk stratification and treatment goals in pulmonary arterial hypertension. The European respiratory journal (2024)
Salaheldin Ahmed, Abdulla Ahmed, Göran Rådegran
Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Pulmonary circulation 14 (1) (2024)
Salaheldin Ahmed, Abdulla Ahmed, Göran Rådegran
Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Pulmonary circulation 14 (1) (2024)
Abdulla Ahmed, Salaheldin Ahmed, Göran Rådegran
Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines. Pulmonary circulation 13 (2) (2023)
Abdulla Ahmed, Salaheldin Ahmed, Daniel Kempe, Göran Rådegran
Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator. European heart journal open 3 (2) (2023)
Abdulla Ahmed, Kriss Kania, Hebba Abdul Rahim, Salaheldin Ahmed, Göran Rådegran
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation. ESC heart failure (2023)
Abdulla Ahmed, Salaheldin Ahmed, Göran Rådegran
Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age-Where do we stand and what's next? Pulmonary circulation 13 (4) (2023)
Abdulla Ahmed, Salaheldin Ahmed, Daniel Kempe, Göran Rådegran
Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator. European heart journal open 3 (2) (2023)
Kriss Kania, Abdulla Ahmed, Salaheldin Ahmed, Göran Rådegran
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension. ESC heart failure (2022)
Mattias Arvidsson, Abdulla Ahmed, Joanna Säleby, Roger Hesselstrand, Göran Rådegran
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension. Pulmonary circulation 12 (1) (2022)
Barbro Kjellström, Habib Bouzina, Erik Björklund, Amélie Beaudet, Susan C Edwards, Roger Hesselstrand, Kjell Jansson, Magnus Nisell, Göran Rådegran, Anna Sandqvist, Håkan Wåhlander, Clara Hjalmarsson, Stefan Söderberg
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension. ESC heart failure 9 (5) (2022)
Mattias Arvidsson, Abdulla Ahmed, Habib Bouzina, Göran Rådegran
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension. ESC heart failure 8 (2) (2021)
Clara Hjalmarsson, Barbro Kjellström, Kjell Jansson, Magnus Nisell, David Kylhammar, Mohammad Kavianipour, Göran Rådegran, Stefan Söderberg, Gerhard Wikström, Dirk M Wuttge, Roger Hesselstrand
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment. ERJ open research 7 (3) (2021)
Salaheldin Ahmed, Abdulla Ahmed, Joanna Säleby, Habib Bouzina, Jakob Lundgren, Göran Rådegran
Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics. Heart and vessels 35 (6) (2020)
Abdulla Ahmed, Salaheldin Ahmed, Mattias Arvidsson, Habib Bouzina, Jakob Lundgren, Göran Rådegran
Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics. ESC heart failure 7 (5) (2020)
Salaheldin Ahmed, Abdulla Ahmed, Habib Bouzina, Jakob Lundgren, Göran Rådegran
Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics. Heart and vessels 35 (11) (2020)
Joanna Säleby, Habib Bouzina, Salaheldin Ahmed, Jakob Lundgren, Göran Rådegran
Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation. ERJ open research 5 (4) (2019)
Abdulla Ahmed, Salaheldin Ahmed, Mattias Arvidsson, Habib Bouzina, Jakob Lundgren, Göran Rådegran
Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics. ESC heart failure 7 (1) (2019)
Barbro Kjellström, Magnus Nisell, David Kylhammar, Sven-Erik Bartfay, Bodil Ivarsson, Göran Rådegran, Clara Hjalmarsson
Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008-2016. ERJ open research 5 (3) (2019)